Transcranial Magnetic Stimulator (TMS) Market Size, Growth, Revenue Share Analysis, Company Profiles, and Forecast To 2028

The Transcranial Magnetic Stimulator (TMS) Market is projected to reach US$ 2,029.71 million by 2028 from US$ 1,122.22 million in 2021; it is expected to register a CAGR of 8.8% from 2021 to 2028.

Neurological disorders affect the brain and nerves of the human body and cause epilepsy and seizures, Parkinson's disease, dementia, autism, Alzheimer's disease, brain tumors, and cerebral palsy, among others. The prevalence of neurological disorders is increasing across the world. According to the Global Burden of Disease Study (GBD) 2017, Alzheimer's disease and other dementias [2.55 million Disability Adjusted Life Years (DALYs)], stroke (about 3.58 million DALYs), and migraine (about 2.40 million DALYs) were the three most burdensome neurological diseases in the US in terms of a total number of disability-adjusted life.

Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00021214?utm_source=OpenPr&utm_medium=10640

Analysis of the Top Market Players:

1. BrainsWay Ltd
2. Nexstim
3. Magstim
4. Neuronetics
5. TMS Neuro Solutions
6. MagVenture, Inc.
7. eNeura Inc.
8. Neurosoft
9. MAG & More GmbH.
10. REMED

In this report, the market has been segmented on the basis of:

Type (Single or Paired Pulse TMS, Repetitive TMS (rTMS))
Age Group (Adults, Children)
Application (Research, Diagnostic, Therapeutic), and Geography

Access full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.premiummarketinsights.com/reports-tip/transcranial-magnetic-stimulator-tms-market

Further, the Alzheimer's Association estimates that over 6 million Americans have Alzheimer's disease, and the number is projected to reach nearly 13 million by 2050. TMS is widely used for the diagnosis and treatment of neurological disorders. For instance, according to BrainsWay Ltd., in April 2021, 100,000 patients across the world were treated with its Deep TMS. Thus, the growing prevalence of neurological disorders drives the growth of the transcranial magnetic stimulator (TMS) market globally. Moreover, depression is one of the mental disorders observed commonly among people worldwide. As per the data published by WHO in January 2020, more than 264 million people of all ages suffer from depression across the world.

Order a copy of this research report at @: https://www.premiummarketinsights.com/buy/TIP00021214?utm_source=OpenPr&utm_medium=10640

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.